A US-based researcher mentioned that the US Food and Drug Administration (FDA) published study surveillance data finds the Pfizer Covid vaccine increases the risk of lung blood clots by 50 per cent.
In the midst of increasing corona cases in the country, the prices of the nasal vaccine given through the nose have been announced today. A dose of nasal vaccine will be given in government hospitals for Rs.325, while it will cost Rs.800 in private hospitals.
Covid-19 vaccines in India: The data showed that 82 per cent of adolescents aged 15 to 18 years have also been vaccinated with the first dose since the vaccination for this age group began on January 3 while 68 per cent have got both the first and second dose.
The DCGI in April also granted an emergency use authorisation (EUA) to Covaxin for the age group of 6-12 years.
Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots.
The Central government had rolled out precautionary doses of Covid-19 vaccine for all adults in private hospitals on April 10.
China has always been notorious about revealing the actual data of new Covid cases, deaths to the world. Most of the people in China have been given the 'Made in China' vaccine like Sinopharm but this hasn't been that effective compared to other vaccines.
The Centre announced on Friday that the precautionary dose of Covid vaccines will be available to everyone aged above 18 years at the private vaccination centers from April 10.
Serum Institute of India's Covid-19 vaccine Covishield was earlier priced at Rs. 600. Bharat Biotech's Covaxin was priced at Rs 1200.
Recently, in a statement on WHO's suspension of Covaxin, Bharat Biotech said, "For the millions who have received Covaxin, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety of the vaccine."
Earlier on Sunday, Bharat Biotech had said it had nothing else to add to an earlier statement where it said it is working on further improvements and upgrades to ensure that the production of Covaxin continues to meet ever increasing global regulatory requirements.
The vaccine manufacturer has further said that the company is slowing down the production of Covaxin for facility optimization.
The inoculation of children in the age group of 12 to 14 years against COVID-19 started on Wednesday with Corbevax vaccine.
The decision was based on a study of 24,000 adults that found the vaccine was 71% effective at preventing COVID-19 - although that was before the omicron variant emerged. Side effects were mild, including fever and fatigue.
Covaxin has already been granted Emergency Use Listing (EUL) in 13 countries.
mRNA vaccines belong to the category of nucleic acid vaccines, which use genetic material from disease-causing virus or pathogen to trigger an immune response against it within the body.
India's COVID-19 vaccination coverage has crossed 156 crore with more than 57 lakh vaccine doses administered on Saturday, the Union health ministry said.
In view of continuous spike in Coronavirus cases in Uttar Pradesh, the state government has started a campaign 'My village, my locality is 100% vaccinated'. Under this, health workers are going door-to-door to check on vaccination (Covid-19 Vaccine). Village heads, NGOs are also contributing in this campaign. INDIA TV's special show 'Ye Public Hai Sab Jaanti Hai' reached Deoria and interacted with doctors, CMOs, health workers as well as people regarding this campaign.
According to reports, Bharat Biotech has proposed that its nasal vaccine can be used as booster dose for those who have already been inoculated with Covaxin or Covishield vaccines against coronavirus.
There are many who are confused if they should get vaccinated if the woman is pregnant or a couple is planning to conceive. There are many questions about the COVID-19 vaccine and fertility, here's what medical experts have to say.
Top News
Latest News
